Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRIX

Nurix Therapeutics Inc

May 08 • 04:00PM ET

16.52

+0.24 1.47 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR ARVN CCCC GLUE RLAY

| Held by: XBI VTI IWM ARKG VXF IWN IBB VTWO SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.16	Insider Own	5.87%	Shs Outstand	103.40M	Perf Week	-1.73%
Market Cap	1.71B	Forward P/E	-	EPS next Y	-2.83	Insider Trans	-2.02%	Shs Float	97.35M	Perf Month	1.72%
Enterprise Value	1.23B	PEG	-	EPS next Q	-0.72	Inst Own	104.85%	Short Float	19.72%	Perf Quarter	-1.96%
Income	-295.28M	P/S	23.80	EPS this Y	3.25%	Inst Trans	35.60%	Short Ratio	18.10	Perf Half Y	32.64%
Sales	71.78M	P/B	3.55	EPS next Y	3.95%	ROA	-47.20%	Short Interest	19.20M	Perf YTD	-12.92%
Book/sh	4.65	P/C	3.16	EPS next 5Y	9.58%	ROE	-61.40%	52W High	22.50 -26.58%	Perf Year	71.37%
Cash/sh	5.23	P/FCF	-	EPS past 3/5Y	6.31% -2.04%	ROIC	-55.05%	52W Low	8.19 101.59%	Perf 3Y	79.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.55% 36.35%	Gross Margin	74.22%	Volatility	5.11% 4.59%	Perf 5Y	-38.68%
Dividend TTM	-	EV/Sales	17.08	EPS Y/Y TTM	-12.53%	Oper. Margin	-439.26%	ATR (14)	0.82	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.01	Sales Y/Y TTM	27.23%	Profit Margin	-411.37%	RSI (14)	50.93	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	6.01	EPS Q/Q	-17.44%	SMA20	-0.97%	Beta	1.86	Target Price	30.18
Payout	-	Debt/Eq	0.12	Sales Q/Q	-66.12%	SMA50	3.63%	Rel Volume	1.22	Prev Close	16.28
Employees	317	LT Debt/Eq	0.12	Earnings	Apr 08 BMO	SMA200	16.11%	Avg Volume	1.06M	Price	16.52
IPO	Jul 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.59% -56.13%	Trades		Volume	1,292,954	Change	1.47%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)